Thyroid Cancer Articles & Analysis
6 news found
The study has recently been published in THYROID®, the leading peer-reviewed journal for original research on thyroid cancer, and can also be accessed by visiting www.thyroiddx.com/pairwise. ...
During the second quarter the Company was notified by Novitas, it’s CME intermediary, that pricing for one of its flagship thyroid cancer screening tests was reduced by 70% retroactive to the beginning of 2022. ...
” RETEVMO was approved by the Food and Drug Administration (FDA) in May 2020 as the first therapy specifically indicated for the treatment of adult patients with metastatic RET fusion-positive non-small cell lung cancer (NSCLC), and the treatment of adult and pediatric patients 12 years of age and older with advanced or metastatic RET-mutant medullary ...
Thermo Fisher Scientific today announced an agreement with Eli Lilly and Company for development of a companion diagnostic that will use the U.S Food and Drug Administration-approved, next-generation sequencing-based Oncomine Dx Target Test to identify certain non-small cell lung cancer (NSCLC) and thyroid cancer patients who may be treated with ...
This agent has the potential to make polyps light up like light bulbs – allowing clinicians to detect and remove more polyps, prevent more cancers and save more lives.” Evidence that colorectal cancer can be prevented by the removal of pre-cancerous lesions and polyps (abnormal growth of tissue) is strong. The EMI-137 agent can help ...
For example, exposure to oestrogen or to oestrogenic EDCs is an accepted risk factor for breast cancer, endometriosis, fibroids and polycystic ovarian syndrome (PCOS) in women. Breast cancer rates are increasing in almost all industrialised countries. The majority of these cases are due to lifestyles and environmental exposures, rather than specific genetic ...